Search for Clinical Trial Results
Carcinoma, Transitional Cell - 25 Studies Found
Status | Study |
Completed |
Study Name: Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy Condition: Urothelial Carcinoma Date: 2011-08-31 Interventions:
|
Completed |
Study Name: Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel Condition: Transitional Cell Carcinoma Date: 2012-08-13 Interventions:
|
Active, not recruiting |
Study Name: Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma Condition: Urinary Tract Urothelial Carcinoma Date: 2008-11-20 Interventions: Drug: Sunitinib Patients are treated with a 6-week inducti |
Active, not recruiting |
Study Name: DNA Methylation and Urothelial Carcinoma Condition: Urothelial Carcinoma Date: 2011-06-20 |
Active, not recruiting |
Study Name: EGCG Modulate the Cytotoxic Effects of Chemotherapeutic Agents in Human Urothelial Carcinoma Cells Condition: Urothelial Carcinoma Date: 2013-10-24 |
Active, not recruiting |
Study Name: The Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial Carcinoma Condition: Bladder Urothelial Carcinoma Date: 2013-10-21 |
Completed |
Study Name: DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma Condition: Urothelial Carcinoma Date: 2011-05-04 Interventions:
|
Completed |
Study Name: Arsenic Methylation Enzymes, Cigarette Metabolites, DNA Repair Enzymes, Inflammatory Factors and Urothelial Carcinoma Condition: Urothelial Carcinoma Date: 2009-03-01 |
Active, not recruiting |
Study Name: Neoadjuvant Erlotinib (Tarceva) in Transitional Cell Carcinoma Condition: Transitional Cell Carcinoma Date: 2008-09-05 Interventions: Drug: Erlotinib Hydrochloride 150 mg (pill) by mouth daily for 3 to 5 weeks prior to surgery |
Recruiting |
Study Name: Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Condition: Urothelial Carcinoma Date: 2016-06-17 Interventions:
|